NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS)

CompletedNA

Sponsor: Guy's and St Thomas' NHS Foundation Trust

Conditions: Asthma, Asthma Attack, Asthma Persistent, Covid19

Interventions: ReferID

Countries: United Kingdom

A digital tool, called ReferID has been developed to facilitate the review of asthma patients. It aims to assist in the identification of patients with uncontrolled and/or severe asthma and to ensure a timely referral to secondary care where appropriate. To validate the tool, patients will be randomised to have a review with a healthcare professional using tool to facilitate the review or to continue receiving usual care. Outcome measures including exacerbation frequency and level of asthma control will be assessed at 12 months.

Eligibility overview

Sex: ALL

Age: 18 Years to 80 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* All asthma patients with 1 of more exacerbations in the last 12 months or receiving high dose inhaled corticosteroids.
* Patients able and willing to provide informed consent.
* Patients aged 18 and over.

Exclusion Criteria:

* Patients who lack capacity.
* Patients who do not have a diagnosis of asthma
* Patients who are unable to provide informed consent
* Patients under the age of 18
* Patients already under a severe asthma centre

Locations (1)

London, United Kingdom